http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Reimagine Staffing: SMART IDEAS Summit 5 Returns with Free Training for a New Era of Sales, Recruiting, and Marketing
-
AST SpaceMobile prices $500 million convertible notes offering
-
AST SpaceMobile repurchases $135 million in convertible notes via stock sale
-
AST SpaceMobile Prices Repurchase of Convertible Senior Notes to be Funded By Concurrent Registered Direct Offering of Class A Common Stock
-
AST SpaceMobile Announces Pricing of Private Offering of $500.0 Million of Convertible Senior Notes Due 2032 (Effective Conversion Price of $120.12 per Share with Capped Call)
-
Lumera Health Launches Revolutionary Web3 Healthcare Infrastructure with LUR Token on Leading Global Exchanges
-
ImmunityBio raises $80 million from institutional investors
-
ImmunityBio, Inc. Announces Execution of $80 Million Equity Financing from Multiple Institutional Investors
-
ImmunityBio Reports 60% Increase in Revenue in Q2 2025, with Year-to-Date Sales of $43 Million and 246% Unit Growth Since J-Code with Regulatory Updates
-
Porter Airlines E195-E2 pilots begin training in Montreal with new Embraer CAE Training Services (ECTS) full-flight simulator
-
Gilead receives positive EU opinion for twice-yearly HIV prevention drug
-
Deepcoin Crypto Futures Data Now Available On TradingView
-
Deepcoin and Upbit Singapore Partner to Enable Cross-Platform Secure Transfers for KYC-Verified Users
-
Stage 8 Presale Live for EVM Layer 2 Meme Coin Little Pepe, With Over $12M Raised in Total
-
Gilead Receives Positive CHMP Opinions Under Accelerated Review From European Medicines Agency for Twice-Yearly Lenacapavir for HIV Prevention
-
Bitget KCGI 2025 Heats Up as Team Battle Kicks Off: Communities Unite, Rivalries Ignite
-
Frontera Energy Provides Notice of Second Quarter 2025 Financial Results Conference Call
-
Troller Cat Enters Stage 14 of Presale with $400K Raised, Announces Ethereum-Based Staking Program
-
Kioxia Commences Sample Shipments of 9th Generation BiCS FLASH™ 512Gb TLC Devices
-
FEARS AROUND SAFETY AND HINDU TEMPLE ATTACKS EMERGE AS KEY CONCERNS AT CAPITOL HILL EVENT
-
Renesas Announces Establishment of New Subsidiary and Changes as Specified Subsidiary
-
Renesas Reports Financial Results for the Second Quarter Ended June 30, 2025
-
Renesas Announces Loss Resulting from Signing Restructuring Support Agreement with Wolfspeed
-
Renesas Announces Consolidated Forecasts
-
QYOM INDIA Showcases Indian Artisanal Craftsmanship in Global Fashion Landscape
-
MultiTech Launches CT300 Wireless Current Transformer for Scalable, Energy Monitoring
-
Ontario International posted its highest June passenger count in history while setting a single-month record for international travelers
-
TriSalus completes exchange offer for preferred stock
-
TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock
-
Exelixis partner Ipsen gets EU approval for neuroendocrine tumor treatment
-
Exelixis’ Partner Ipsen Receives European Commission Approval for CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors
-
MilliporeSigma and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration
-
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
-
Keesler Federal Sponsors LSU Athletics
-
PepsiCo Declares Quarterly Dividend
-
Greenberg Traurig's Michael Burshteyn Named Law360 Rising Star
-
AST SpaceMobile announces $500 million convertible notes offering
-
AST SpaceMobile plans $135 million convertible note repurchase
-
AST SpaceMobile Announces Proposed Repurchase of up to $135.0 Million Convertible Senior Notes to be Funded by Concurrent Registered Direct Offering of Class A Common Stock
-
AST SpaceMobile Announces Proposed Private Offering of $500.0 Million of Convertible Senior Notes Due 2032
-
Gilead Sciences to Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
-
Celcuity begins Phase 3 trial for advanced breast cancer drug
-
Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-2 Clinical Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer
-
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 11, 2025
-
Analog Devices, Inc. to Report Third Quarter Fiscal Year 2025 Financial Results on Wednesday, August 20, 2025
-
HumanRaiders Is Changing How Crypto Projects Go Viral - No KOLs, No Bots
-
Accesorios Reveals 150,000 Loyal Customers Built Through Six-Year Stealth Growth Strategy
-
Bitget Strengthens Regional Presence at Malaysia Blockchain Week 2025
-
Greenberg Traurig Adds Strength to Strength in its market-leading Middle Eastern, European, and Global Hospitality Practice with Addition of Elias J. Hayek in UAE and KSA
-
LFG!!! Launches AI Alpha Pilot for Meme-Coin Hunters

